GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 59-66

  Krausz, L T ^a   Fischer Fodor, E ^b   Major, Z Zs ^a   Fetica, B ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

Author keywords

CD127; CD25; GITR; GITRL; Lymph node; Treg

Indexed keywords

CD28 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; LIGAND; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER PATIENT; CASE REPORT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STAINING; CONTROLLED STUDY; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TUMOR MICROENVIRONMENT;

EID: 84861476403     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500108     Document Type: Article

References (30)

1. de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst 2010; 102:410-25.
2. Alam SM, Clark JS, George WD, Campbell AM. Altered lymphocyte populations in tumour invaded nodes of breast cancer patients. Immunol Lett 1993; 35:229-34. (Pubitemid 23109008)
3. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2005; 2:e284.
4. Changsri C, Prakash S, Sandweiss L, Bose S. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J 2004; 10:392-7. (Pubitemid 39281310)
5. Watanabe MA, Oda JM, Amarante MK, Cesar Voltarelli J. Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis Rev 2010; 29:569-79.
6. Gupta R, Babb JS, Singh B, Chiriboga L, Liebes L, Adams S, Demaria S. The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status. Cancer Invest 2011; 29:419-25.
7. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R, Migliorati G, Riccardi C. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997;94:6216-21. (Pubitemid 27270664)
8. Nocentini G, Riccardi C. GITR: a modulator of immune response and inflammation. Adv Exp Med Biol 2009; 647:156-73.
9. Krausz LT, Bianchini R, Ronchetti S, Fettucciari K, Nocentini G, Riccardi C. GITR-GITRL system, a novel player in shock and inflammation. ScientificWorldJournal 2007; 7:533-66.
10. Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, Collins M, Shevach EM. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004; 173:5008-20. (Pubitemid 39387783)
11. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3: 135-42. (Pubitemid 34141443)
12. Ronchetti S, Nocentini G, Bianchini R, Krausz LT, Migliorati G, Riccardi C Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells. J Immunol 2007; 179:5916-26.
13. Tone M, Tone Y, Adams E, Yates SF, Frewin MR, Cobbold SP, Waldmann H. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA 2003; 100:15059-64. (Pubitemid 37518016)
14. Cuzzocrea S, Ayroldi E, Di Paola R, et al. Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB J 2005; 19:1253-65. (Pubitemid 41113722)
15. Cuzzocrea S, Ronchetti S, Genovese T, et al. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB J 2007; 21:117-29. (Pubitemid 46052551)
16. Bianchini R, Bistoni O, Alunno A, et al. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Eur J Immunol 2011; 41:2269-78.
17. Gerli R, Nocentini G, Alunno A, Bocci EB, Bianchini R, Bistoni O, Riccardi C Identification of regulatory T cells in systemic lupus erythematosus. Autoimmun Rev 2009; 8:426-30.
18. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-700. (Pubitemid 44036275)
19. Liu W, Putnam AL, Xu-Yu Z, et al. CD 127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203:1701-11. (Pubitemid 44036276)
20. Alunno A, Nocentini G, Bistoni O, Bianchini R, Bartoloni Bocci E, Riccardi C, Gerli R. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25 cell subset in patients with systemic lupus erythematosus]. Reumatismo 2010; 62:195-201.
21. Whiteside TL. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol 2006; 16:3-15. (Pubitemid 43139705)
22. Matsuura K, Yamaguchi Y, Osaki A, Ohara M, Okita R, Emi A, Murakami S, Arihiro K. FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients. Oncol Rep 2009; 22: 1181-7.
23. Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G, Ayroldi E, Riccardi C. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 2004; 34:613-22. (Pubitemid 39255908)
24. Kim YS, Jung HW, Choi J, Kwon BS, Ham SY, Jung AK, Ko BK. Expression of AITR and AITR ligand in breast cancer patients. Oncol Rep 2007; 18:1189-94.
25. Ronchetti S, Nocentini G, Petrillo MG, Bianchini R, Sportoletti P, Bastianelli A, Ayroldi EM, Riccardi C. Glucocorticoid-induced TNFR family Related gene (GITR) enhances dendritic cell activity. Immunol Lett 2011; 135:24-33.
26. Curti A, Pandolfi S, Valzasina B, et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory. cells. Blood 2007; 109:2871-7. (Pubitemid 46482083)
27. Grohmann U, Volpi C, Fallarino F, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007; 13:579-86. (Pubitemid 46828479)
28. Baessler T, Krusch M, Schmiedet BJ, Kloss M, Baltz KM, Wacker A, Schmetzer HM, Salih HR. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. Cancer Res 2009; 69:1037-45.
29. Baltz KM, Krusch M, Bringmann A, et al. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/ tumor cell interactions. FASEB J 2007; 21:2442-54. (Pubitemid 47230674)
30. Nocentini G, Ronchetti S, Petrillo MG, Riccardi C. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives. Br J Pharmacol 2011: Epub ahead of print.